Global Demineralized Bone Matrix (DBM) Market Report 2018-2029
1 Industry Overview of Demineralized Bone Matrix (DBM)
- 1.1 Research Scope
- 1.2 Market Segmentation by Types of Demineralized Bone Matrix (DBM)
- 1.3 Market Segmentation by End Users of Demineralized Bone Matrix (DBM)
- 1.4 Market Dynamics Analysis of Demineralized Bone Matrix (DBM)
- 1.4.1 Market Drivers
- 1.4.2 Market Challenges
- 1.4.3 Market Opportunities
- 1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Demineralized Bone Matrix (DBM) Industry
- 2.1 Medtronic
- 2.1.1 Company Overview
- 2.1.2 Main Products and Specifications
- 2.1.3 Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.1.4 Contact Information
- 2.2 J &J (DePuy Synthes)
- 2.2.1 Company Overview
- 2.2.2 Main Products and Specifications
- 2.2.3 Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.2.4 Contact Information
- 2.3 Zimmer
- 2.3.1 Company Overview
- 2.3.2 Main Products and Specifications
- 2.3.3 Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.3.4 Contact Information
- 2.4 Stryker Corporation
- 2.4.1 Company Overview
- 2.4.2 Main Products and Specifications
- 2.4.3 Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.4.4 Contact Information
- 2.5 Straumann
- 2.5.1 Company Overview
- 2.5.2 Main Products and Specifications
- 2.5.3 Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.5.4 Contact Information
- 2.6 RTI Surgical
- 2.6.1 Company Overview
- 2.6.2 Main Products and Specifications
- 2.6.3 Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.6.4 Contact Information
- 2.7 Surgical Esthetics
- 2.7.1 Company Overview
- 2.7.2 Main Products and Specifications
- 2.7.3 Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
- 2.7.4 Contact Information
3 Global Demineralized Bone Matrix (DBM) Market Analysis by Regions, Manufacturers, Types and End Users
- 3.1 Global Sales Volume and Revenue of Demineralized Bone Matrix (DBM) by Regions (2018-2023)
- 3.2 Global Sales Volume and Revenue of Demineralized Bone Matrix (DBM) by Manufacturers (2018-2023)
- 3.3 Global Sales Volume and Revenue of Demineralized Bone Matrix (DBM) by Types (2018-2023)
- 3.4 Global Sales Volume and Revenue of Demineralized Bone Matrix (DBM) by End Users (2018-2023)
- 3.5 Selling Price Analysis of Demineralized Bone Matrix (DBM) by Regions, Manufacturers, Types and End Users in (2018-2023)
4 Northern America Demineralized Bone Matrix (DBM) Market Analysis by Countries, Types and End Users
- 4.1 Northern America Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 4.2 Northern America Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Types (2018-2023)
- 4.3 Northern America Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 4.4 United States Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 4.5 Canada Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5 Europe Demineralized Bone Matrix (DBM) Market Analysis by Countries, Types and End Users
- 5.1 Europe Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 5.2 Europe Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Types (2018-2023)
- 5.3 Europe Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 5.4 Germany Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.5 France Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.6 UK Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.7 Italy Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.8 Russia Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.9 Spain Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 5.10 Netherlands Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6 Asia Pacific Demineralized Bone Matrix (DBM) Market Analysis by Countries, Types and End Users
- 6.1 Asia Pacific Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 6.2 Asia Pacific Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Types (2018-2023)
- 6.3 Asia Pacific Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 6.4 China Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.5 Japan Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.6 Korea Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.7 India Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.8 Australia Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.9 Indonesia Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 6.10 Vietnam Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7 Latin America Demineralized Bone Matrix (DBM) Market Analysis by Countries, Types and End Users
- 7.1 Latin America Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 7.2 Latin America Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Types (2018-2023)
- 7.3 Latin America Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 7.4 Brazil Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.5 Mexico Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.6 Argentina Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 7.7 Colombia Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8 Middle East & Africa Demineralized Bone Matrix (DBM) Market Analysis by Countries, Types and End Users
- 8.1 Middle East & Africa Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Countries (2018-2023)
- 8.2 Middle East & Africa Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by Types (2018-2023)
- 8.3 Middle East & Africa Demineralized Bone Matrix (DBM) Sales Volume and Revenue Analysis by End Users (2018-2023)
- 8.4 Turkey Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.5 Saudi Arabia Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.6 South Africa Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
- 8.7 Egypt Demineralized Bone Matrix (DBM) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
- 9.1 Marketing Channel
- 9.1.1 Direct Channel
- 9.1.2 Indirect Channel
- 9.2 Distributors and Traders
10 Global Demineralized Bone Matrix (DBM) Market Forecast by Regions, Countries, Manufacturers, Types and End Users
- 10.1 Global Sales Volume and Revenue Forecast of Demineralized Bone Matrix (DBM) by Regions (2024-2029)
- 10.2 Global Sales Volume and Revenue Forecast of Demineralized Bone Matrix (DBM) by Types (2024-2029)
- 10.3 Global Sales Volume and Revenue Forecast of Demineralized Bone Matrix (DBM) by End Users (2024-2029)
- 10.4 Global Revenue Forecast of Demineralized Bone Matrix (DBM) by Countries (2024-2029)
- 10.4.1 United States Revenue Forecast (2024-2029)
- 10.4.2 Canada Revenue Forecast (2024-2029)
- 10.4.3 Germany Revenue Forecast (2024-2029)
- 10.4.4 France Revenue Forecast (2024-2029)
- 10.4.5 UK Revenue Forecast (2024-2029)
- 10.4.6 Italy Revenue Forecast (2024-2029)
- 10.4.7 Russia Revenue Forecast (2024-2029)
- 10.4.8 Spain Revenue Forecast (2024-2029)
- 10.4.9 Netherlands Revenue Forecast (2024-2029)
- 10.4.10 China Revenue Forecast (2024-2029)
- 10.4.11 Japan Revenue Forecast (2024-2029)
- 10.4.12 Korea Revenue Forecast (2024-2029)
- 10.4.13 India Revenue Forecast (2024-2029)
- 10.4.14 Australia Revenue Forecast (2024-2029)
- 10.4.15 Indonesia Revenue Forecast (2024-2029)
- 10.4.16 Vietnam Revenue Forecast (2024-2029)
- 10.4.17 Brazil Revenue Forecast (2024-2029)
- 10.4.18 Mexico Revenue Forecast (2024-2029)
- 10.4.19 Argentina Revenue Forecast (2024-2029)
- 10.4.20 Colombia Revenue Forecast (2024-2029)
- 10.4.21 Turkey Revenue Forecast (2024-2029)
- 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
- 10.4.23 South Africa Revenue Forecast (2024-2029)
- 10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Demineralized Bone Matrix (DBM)
- 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Demineralized Bone Matrix (DBM)
- 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Demineralized Bone Matrix (DBM)
- 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Demineralized Bone Matrix (DBM)
- 11.2 Downstream Major Consumers Analysis of Demineralized Bone Matrix (DBM)
- 11.3 Major Suppliers of Demineralized Bone Matrix (DBM) with Contact Information
- 11.4 Supply Chain Relationship Analysis of Demineralized Bone Matrix (DBM)
12 Demineralized Bone Matrix (DBM) New Project Investment Feasibility Analysis
- 12.1 Demineralized Bone Matrix (DBM) New Project SWOT Analysis
- 12.2 Demineralized Bone Matrix (DBM) New Project Investment Feasibility Analysis
- 12.2.1 Project Name
- 12.2.2 Investment Budget
- 12.2.3 Project Product Solutions
- 12.2.4 Project Schedule
13 Demineralized Bone Matrix (DBM) Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.2 References and Data Sources
- 14.2.1 Primary Sources
- 14.2.2 Secondary Paid Sources
- 14.2.3 Secondary Public Sources
- 14.3 Abbreviations and Units of Measurement
- 14.4 Author Details
Demineralized Bone Matrix (DBM) is a medical implant derived from allograft bone that has undergone a process of demineralization to remove inorganic components while preserving the organic matrix. DBM is used to promote bone growth and regeneration in orthopedic, spinal, and dental surgeries. The global Demineralized Bone Matrix (DBM) market size is projected to reach US$624 million by 2022, with a compound annual growth rate of 4.3%. The growth is attributed to the increasing prevalence of bone-related disorders and rising demand for minimally invasive surgical procedures.
DBM products are primarily used in Orthopedics, Spinal, and Dental surgeries. Among these, Orthopedics dominate the market due to the high occurrence of fractures, osteoporosis, and degenerative bone diseases. The Spinal category is also expected to witness significant growth in the coming years owing to the increasing preference for minimally invasive surgeries and the high incidence of spinal injuries and degeneration.
The major global manufacturers in the Demineralized Bone Matrix (DBM) industry are Medtronic, J&J (DePuy Synthes), Zimmer, Stryker Corporation, Straumann, RTI Surgical, and Surgical Esthetics. These companies are involved in product development, research, and development, marketing, and distribution.
North America dominates the Demineralized Bone Matrix (DBM) market, followed by Europe and the Asia-Pacific region. The high incidence of organ-related disorders, sophisticated healthcare infrastructure, and favorable reimbursement policies contribute to the dominance of the North American region. The Asia-Pacific region presents significant growth opportunities due to a large population base, increasing disposable income, and a growing emphasis on healthcare infrastructure.
Despite the growing market, there are still some challenges that manufacturers face that may limit growth prospects. These challenges include stringent regulatory requirements for product safety and efficacy, competition from alternative bone graft substitutes, and the high cost of DBM products.
In conclusion, the Demineralized Bone Matrix (DBM) industry is projected to witness significant growth in the coming years due to the increasing prevalence of bone-related disorders and rising demand for minimally invasive surgical procedures. The major global manufacturers are investing in research and development to create innovative products and expand their market share. North America dominates the market, followed by Europe and the Asia-Pacific region. However, challenges such as regulatory requirements, competition from alternative bone graft substitutes, and the high cost of DBM products can limit adoption and growth. Manufacturers should focus on innovation, reducing costs, improving product quality and safety, developing innovative products that meet changing customer needs, and targeting emerging markets to overcome these challenges and sustain growth in the long term.
The SWOT analysis of the Demineralized Bone Matrix (DBM) industry is as follows:
Strengths:
DBM is a proven bone graft substitute with a high success rate in promoting bone growth and regeneration, which makes it a preferred choice for orthopedic, spinal, and dental surgeries.
The Demineralized Bone Matrix (DBM) industry caters to a growing demand for minimally invasive surgical procedures that reduce patient discomfort, recovery time and hospital stays.
Increasing investments in research and development by major global manufacturers lead to the development of innovative products that better meet customer needs.
Rising healthcare spending, demographics, and lifestyles contribute to growing demand for orthopedic implants.
Weaknesses:
The high cost of DBM products can limit adoption, especially in developing countries.
Stringent regulatory requirements for product safety and efficacy increase the cost of manufacturing and delay product launches.
DBM products have limited availability due to the limited supply of bone tissue donors and the complexity of demineralization process.
Opportunities:
The increasing prevalence of bone-related disorders and rising demand for minimally invasive surgical procedures create significant growth opportunities for the DBM industry.
Advancements in biotechnology, such as tissue engineering, create opportunities for manufacturers to develop innovative products that offer better performance and safety profiles.
The adoption of online shopping provides new growth opportunities for manufacturers to reach more customers.
Threats:
Competition from alternative bone graft substitutes, such as synthetic bone grafts or autografts, can limit the industry's growth prospects.
Economic volatility and political instability in some regions can affect the demand for DBM products.
The potential complications and side effects of DBM products, such as infection or inflammation, can lead to negative publicity and affect the industry's reputation.
Key players in global Demineralized Bone Matrix (DBM) market include:
Medtronic
J &J (DePuy Synthes)
Zimmer
Stryker Corporation
Straumann
RTI Surgical
Surgical Esthetics
Market segmentation, by product types:
Gel
Putty
Putty with Chips
Market segmentation, by applications:
Orthopedics
Spinal
Dental